Physician profile
Seth Oringher
NPI 1821061854
$429,261.49
in general payments reported to CMS, 2019-2025
15 companies · $135K in 2025
The $135K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $76.99 · 2021: $15K · 2022: $82K · 2023: $118K · 2024: $79K · 2025: $135K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $253K · Travel and Lodging: $61K · Consulting Fee: $9,200 · Food and Beverage: $8,816 · Grant: $61.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $252,800.00 |
| Travel and Lodging | $61,341.21 |
| Consulting Fee | $9,200.00 |
| Food and Beverage | $8,816.36 |
| Grant | $61.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $427,728.71 | 2021-2025 | Nucala |
| Optinose US, INC. | $390.32 | 2019-2023 | |
| Genzyme Corporation | $276.99 | 2023-2025 | |
| Acclarent, INC | $203.31 | 2019-2021 | |
| Medtronic USA, INC. | $160.70 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $151.97 | 2021-2025 | Dupixent |
| Medtronic, INC. | $108.61 | 2022 | |
| Stryker Corporation | $58.28 | 2022-2024 | Scopis Ent |
| Neurent Medical Limited | $41.70 | 2022 | |
| Arbor Pharmaceuticals, INC. | $40.57 | 2019 | |
| Smith+Nephew, INC. | $33.14 | 2021 | |
| Aerin Medical INC. | $19.65 | 2025 | |
| Amgen INC. | $17.04 | 2025 | Tezspire |
| Hikma Pharmaceuticals USA | $15.28 | 2025 | Ryaltris |
| Merck Sharp & Dohme LLC | $15.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Oringher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.